Researchers discovered a new eukaryotic CRISPR-Cas homolog, Fanzor2, with potential for advanced genomic engineering.

Researchers have discovered a new eukaryotic CRISPR-Cas homolog named Fanzor2, which may enhance gene editing techniques. Utilizing cryo-electron microscopy, scientists at St. Jude Children's Research Hospital examined Fanzor2's structure, revealing its potential for genomic engineering. Unlike Cas9, Fanzor2 may be smaller and offer unique functionalities, paving the way for advanced RNA-guided nucleases and applications in medicine and agriculture.

October 01, 2024
4 Articles

Further Reading